Anti-Inosine triphosphate pyrophosphatase抗體[EPR8779]
產品名稱: Anti-Inosine triphosphate pyrophosphatase抗體[EPR8779]
英文名稱: C20orf37 antibody dJ794I6.3 antibody HLC14-06-P antibody Inosine triphosphatase (nucleoside triphosphate pyrophosphatase) antibody Inosine triphosphat
產品編號: ab150420
產品價格: null
產品產地: 英國
品牌商標: abcam
更新時間: null
使用范圍:
- 聯系人 :
- 地址 : 深圳市寶安區西鄉寶民二路賢基大廈4E
- 郵編 :
- 所在區域 : 廣東
- 電話 : 133****4454 點擊查看
- 傳真 : 點擊查看
- 郵箱 : 1484332550@qq.com
?
- 經測試應用WB,?Flow Cytmore details
- 種屬反應性
與反應:?Mouse, Rat, Human
- 免疫原
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) (internal sequence)
- 陽性對照
- Jurkat, HepG2, HeLa and K562 cell lysates; permeabilized HeLa cells.
- 常規說明
This product is a recombinant rabbit monoclonal antibody.
Produced using Abcam’s RabMAb??technology. RabMAb??technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
性能
- 形式Liquid
- 存放說明Shipped at 4°C. Store at -20oC.
- 存儲溶液Preservative: 0.01% Sodium azide
Constituents: 50% Glycerol, 0.05% BSA - 純度Tissue culture supernatant
- 克隆單克隆
- 克隆編號EPR8779
- 同種型IgG
- 研究領域
應用
Our?Abpromise guarantee?covers the use of?ab150420?in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
- 應用說明Is unsuitable for ICC,IHC-P or IP.
靶標
- 功能Hydrolyzes ITP and dITP to their respective monophosphate derivatives. Xanthosine 5'-triphosphate (XTP) is also a potential substrate. May be the major enzyme responsible for regulating ITP concentration in cells.
- 組織特異性Ubiquitous. Highly expressed in heart, liver, sex glands, thyroid and adrenal gland.
- 疾病相關Defects in ITPA are the cause of inosine triphosphate pyrophosphohydrolase deficiency (ITPA deficiency) [MIM:147520]. It is a common inherited trait characterized by the abnormal accumulation of inosine triphosphate (ITP) in erythrocytes and also leukocytes and fibroblasts. The pathological consequences of ITPA deficiency, if any, are unknown. However, it might have pharmacogenomic implications and be related to increased drug toxicity of purine analog drugs. Three different human populations have been reported with respect to their ITPase activity: high, mean (25% of high) and low activity. The variant Thr-32 is associated with complete loss of enzyme activity, may be by altering the local secondary structure of the protein. Heterozygotes for this polymorphism have 22.5% of the control activity: this is consistent with a dimeric structure of the enzyme.
- 序列相似性Belongs to the HAM1 NTPase family.
- 細胞定位Cytoplasm.
- Information by UniProt
-
數據庫鏈接
- Entrez Gene: 3704?Human
- Entrez Gene: 16434?Mouse
- Entrez Gene: 311422?Rat
- Omim: 147520?Human
- SwissProt: Q9BY32?Human
- SwissProt: Q9D892?Mouse
- SwissProt: D3ZW55?Rat
- Unigene: 415299?Human
see all -
別名
- C20orf37 antibody
- dJ794I6.3 antibody
- HLC14-06-P antibody
see all
Anti-Inosine triphosphate pyrophosphatase antibody [EPR8779] 圖像
-
All lanes :?Anti-Inosine triphosphate pyrophosphatase antibody [EPR8779] (ab150420) at 1/1000 dilution
Lane 1 :?Jurkat cell lysate
Lane 2 :?HepG2 cell lysate
Lane 3 :?HeLa cell lysate
Lane 4 :?K562 cell lysate
Lysates/proteins at 10 μg per lane.
Predicted band size :?21 kDa
-
Flow cytometric analysis of permeabilized HeLa cells labeling Inosine triphosphate pyrophosphatase with ab150420 at 1/10 dilution(red) comapred with a rabbit IgG negative control (green).

![Western blot - Anti- Inosine triphosphate pyrophosphatase antibody [EPR8779] (ab150420)](http://www.abcam.cn/ps/datasheet/images/150/ab150420/-Inosine-triphosphate-pyrophosphatase-Primary-antibodies-ab150420-1.jpg)